*Article not assigned to an issue yet
Mc Lean D. Capistrano Bryant, Cueto Shantae Marie Gabrielle J., Sarmiento Aneirin Lleyke T., Canivel Renzo Luis C., Hernandez Gerald Glenn A., Calaramo Michael A., Alejandro Grecebio Jonathan D.
Keywords: Alzheimer’s disease, Anti-amyloidogenic, Advanced glycation end products, Antioxidant, n Psychotria luzoniensisn , n Psychotria banahaensisn , Rubiaceae
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by the presence of amyloid-beta (Aβ) plaques in the brain, and studies have linked the formation of these plaques with oxidative stress and advanced glycation end products (AGEs). Two endemic Philippine Psychotria species from Ilocos Norte, Psychotria luzoniensis (Cham. & Schltdl.) Fern.-Vill. and Psychotria banahaensis Elmer., are evaluated for their pharmacological activities. Following methanolic extraction, P. luzoniensis leaf extract (PLLE) and P. banahaensis leaf extract (PBLE) were examined for their total phenolic and flavonoid content, antioxidant activity, inhibition of AGEs formation, and anti-amyloidogenic activity. Phytochemical profiling of both Psychotria leaf extracts revealed that PLLE showed higher TPC (16.36 ± 0.87 mg GAE/g DW) and TFC (3.54 ± 0.23 mg QE/g DW) values compared to PBLE, which corresponds to its high antioxidant activity (%Decolorization = 97.33 ± 0.72% | TEAC = 183.55 ± 1.46 mg TE/kg). Regarding anti-AGE activity, despite PBLE showed a higher percent AGE inhibition, PLLE was found to be more potent (IC50 = 335.75 ppm). Interestingly, both crude extracts were able to show potential in inhibiting Aβ aggregation (percentage inhibitions of 75.23 and 65.72% at 100 μg/mL). The data indicates that both PLLE and PBLE, show promising activities that may be harnessed through further studies to formulate novel forms of treatments against AD.
Agbor GA, Vinson JA, Donnelly PE (2014) Folin-Ciocalteau reagent for polyphenolic assay. Int J Food Sci Nutr Diet 3:147–156. https://doi.org/10.19070/2326-3350-1400028
Arvouet-Grand A, Vennat B, Pourrat A, Legret P (1994) Standardization of propolis extract and ıdentification of principal constituents. J Pharm Belg 49:462–468
Ashrafian H, Zadeh EH, Khan RH (2021) Review on Alzheimer’s disease: Inhibition of amyloid beta and tau tangle formation. Int J Biol Macromol 167:382–394. https://doi.org/10.1016/j.ijbiomac.2020.11.192
Aureada MY, Duran JD, Falcatan SR, Pornillos KM, Villanueva MA, Ordas JA, Tan MA (2023) Correlation of total phenolic and flavonoid contents on the antioxidant activity of Psychotria gitingensis and Psychotria pilosella. J Phytol 15: 110–115. https://doi.org/10.25081/jp.2023.v15.8545
Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C (2021) Early-onset Alzheimer’s disease: what ıs missing ın research? Curr Neurol Neurosci 21:4. https://doi.org/10.1007/s11910-020-01090-y
Butterfield DA, Boyd-Kimball D (2018) Oxidative stress, amyloid-Β peptide, and altered key molecular pathways ın the pathogenesis and progression of Alzheimer’s disease. J Alzheimers Dis 62:1345–1367. https://doi.org/10.3233/JAD-170543
Cepas V, Collino M, Mayo JC, Sainz RM (2020) Redox Signaling and advanced glycation end products (AGEs) ın diet-related diseases. Antioxidants 9:142. https://doi.org/10.3390/antiox9020142
Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) oxidative stress and the amyloid beta peptide ın Alzheimer’s disease. Redox Biol 14:450–464. https://doi.org/10.1016/j.redox.2017.10.014
Espargaró A, Ginex T, Vadell MD, Busquets MA, Estelrich J, Muñoz-Torrero D, Luque FJ, Sabate R (2017) Combined ın vitro cell-based/ın silico screening of naturally occurring flavonoids and phenolic compounds as potential anti-Alzheimer drugs. J Nat Prod 80:278–289. https://doi.org/10.1021/acs.jnatprod.6b00643
Formagio ASN, Vilegas W, Volobuff CRF, Leite Kassuya CA, Lima Cardoso CA, Pereira ZV, Silva RM, Yamazaki DA, Gauza G, Manfron J, Marangoni JA (2022) Exploration of essential oil from Psychotria poeppigiana as an anti-hyperalgesic and anti-acetylcholinesterase agent: chemical composition, biological activity and molecular docking. J Ethnopharm 296:115220. https://doi.org/10.1016/j.jep.2022.115220
Gajula D, Verghese M, Boateng J, Walker LT, Shackelford L, Mentreddy SR, Cédric S (2009) Determination of total phenolics, flavonoids and antioxidant and chemopreventive potential of basil (Ocimum basilicum L. and Ocimum tenuiflorum L.). J Cancer Res 5:130–143. https://doi.org/10.3923/ijcr.2009.130.143
Gonzalez-Ruiz C, Hidalgo I, Portilla-Martínez A, Rubio-Gayosso I, Salgado-Ceballos H, Fabela-Sánchez O, Bernal-Hernandez J, Ortiz-Flores M (2025) Phytochemical compounds against mild cognitive impairment key proteins: an in-silico approach. J Appl Pharm Sci 15:90–101. https://doi.org/10.7324/JAPS.2025.209505
Grzegorczyk-Karolak I, Gołąb K, Gburek J, Wysokińska H, Matkowski A (2016) Inhibition of advanced glycation end-product formation and antioxidant activity by extracts and polyphenols from Scutellaria alpina L. and S altissima L. Molecules 21:739. https://doi.org/10.3390/molecules21060739
Hassanpour SH, Doroudi A (2023) Review of the antioxidant potential of flavonoids as a subgroup of polyphenols and partial substitute for synthetic antioxidants. Avicenna J Phytomed 13: 354–376. https://doi.org/10.22038/AJP.2023.21774
Hellinger R, Koehbach J, Puigpinós A, Clark RJ, Tarragó T, Giralt E, Gruber CW (2015) Inhibition of human prolyl oligopeptidase activity by the cyclotide psysol 2 isolated from Psychotria solitudinum. J Nat Prod 78:1073–1082. https://doi.org/10.1021/np501061t
Jahan H, Choudhary MI (2015) Glycation, carbonyl stress and ages inhibitors: a patent review. Expert Opin Ther Pat 25:1267–1284. https://doi.org/10.1517/13543776.2015.1076394
Jariyapamornkoon N, Yibchok-Anun S, Adisakwattana S (2013) Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity. BMC Complement Altern Med 13:171. https://doi.org/10.1186/1472-6882-13-171
Kang S, Lee YH, Lee JE (2017) Metabolism-centric overview of the pathogenesis of Alzheimer’s disease. Yonsei Med J 58:479–488. https://doi.org/10.3349/ymj.2017.58.3.479
Kirchweger B, Klein-Junior LC, Pretsch D, Chen Y, Cretton S, Gasper AL, Heyden YV, Christen P, Kirchmair J, Henriques AT, Rollinger JM (2022) Azepine-indole alkaloids from Psychotria nemorosa modulate 5-Ht2 A receptors and prevent in vivo protein toxicity in transgenic Caenorhabditis elegans. Front Neurosci 16:826289. https://doi.org/10.3389/fnins.2022.826289
Martins D, Nunez CV (2015) Secondary metabolites from Rubiaceae species. Molecules 20:13422–13495. https://doi.org/10.3390/molecules200713422
Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A (2022) Hippocampus and ıts ınvolvement ın Alzheimer’s disease: a review. 3 Biotech 12:55. https://doi.org/10.1007/s13205-022-03123-4
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med 26:1231–1237. https://doi.org/10.1016/S0891-5849(98)00315-3
Sacconnay L, Ryckewaert L, dos Santos PC, Guerra MC, Kato L, Alves de Oliveira CM, Henriques A, Carrupt PA, Simones-Pires C, Nurisso A (2015) Alkaloids from Psychotria target sirtuin: In silico and in vitro interaction studies. Planta Med 81:517–524. https://doi.org/10.1055/s-0034-1383261
Sangeetha M, Banurekha J (2020) Psychotria-an Overview. Res J Pharm Technol 13:5484–5488. https://doi.org/10.5958/0974-360X.2020.00957.9
Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH (2022) Amyloid beta in aging and Alzheimer’s disease. Int J Mol Sci 23:12924. https://doi.org/10.3390/ijms232112924
Sharma H, Sharma N, An SSA (2023) Black pepper (Piper nigrum) alleviates oxidative stress, exerts potential anti-glycation and anti-ache activity: a multitargeting neuroprotective agent against neurodegenerative diseases. Antioxidants 12:1089. https://doi.org/10.3390/antiox12051089
Silva MVF, Loures CDMG, Alves LCV, De Souza LC, Borges KBG, Carvalho MDG (2019) Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci 26:33. https://doi.org/10.1186/s12929-019-0524-y
Singh P, Jayaramaiah RH, Agawane SB, Vannuruswamy G, Korwar AM, Anand A, Dhaygude V, Shaikh ML, Joshi RS, Boppana R, Kulkarni MJ, Thulasiram HV, Giri AP (2016) Potential dual role of eugenol ın ınhibiting advanced glycation end products ın diabetes: proteomic and mechanistic ınsights. Sci Rep 6:18798. https://doi.org/10.1038/srep18798
Soares D, Duarte L, Cavalcanti A, Silva F, Braga A, Lopes M, Takahashi J, Vieira-Filho S (2017) Psychotria viridis: chemical constituents from leaves and biological properties. An Acad Bras Cienc 89:927–938. https://doi.org/10.1590/0001-3765201720160411
Starowicz M, Zieliński H (2019) Inhibition of advanced glycation end-product formation by high antioxidant-leveled spices commonly used in European cuisine. Antioxidants 8:100. https://doi.org/10.3390/antiox8040100
Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M (2021) Oxidative stress and beta amyloid In Alzheimer’s disease. Which comes first: the chicken or the egg? Antioxidants 10:1479. https://doi.org/10.3390/antiox10091479
Tan MA, Ishikawa H, An SSA (2022) Pandanus amaryllifolius exhibits in vitro anti-amyloidogenic activity and promotes neuroprotective effects in amyloid-β-induced SH-SY5Y cells. Nutrients 14:3962. https://doi.org/10.3390/nu14193962
Tan MA, Manzano JAH, Ishikawa H (2024) Amyloid-beta aggregation and advanced glycation end-products inhibitory activities of Pandanus amaryllifolius Roxb. alkaloids: insights from in vitro and computational investogations. Chem Pap 78:9359–9367. https://doi.org/10.1007/s11696-024-03747-1
Villegas S, Roda A, Serra-Mir G, Montoliu-Gaya L, Tiessler L (2022) Amyloid-beta peptide and tau protein crosstalk ın Alzheimer’s disease. Neural Regen Res 17:1666. https://doi.org/10.4103/1673-5374.332127
College of Science, University of Santo Tomas, Manila, Philippines